Comparison of the effect of treatment with the main groups of antihypertensive drugs on the quality of life in patients with stable arterial hypertension


Cite item

Full Text

Abstract

When appointing antihypertensive drugs to patients with stable mild to moderate arterial hypertension (AH) it is necessary to take into account the effect of treatment on the quality of life (QoL) of these patients. The aim of the study was to compare the effect of prolonged use of antihypertensive drugs from the main treatment groups on QoL of patients with stable AH in 5 controlled trials. The results of monotherapy efficacy were assessed by 24-hour blood pressure monitoring and QoL patients were studied before and after long-term monotherapy according to the results of a database analysis of 5 studies performed in our center for the last 4 years. After the period of withdrawal of antihypertensive therapy, patients underwent 24-hour blood pressure monitoring, QoL was evaluated. According to 24-hour blood pressure monitoring, diltiazem had an antihypertensive effect, comparable to the effect of enalapril. Both drugs had no effect on the circadian rhythm of arterial pressure and the outpatient heart rate. Long-term use of none of the antihypertensive drugs (diltiazem, amlodipine, enalapril, metoprolol, telmisartan) did not worsen QoL. The greatest impact on QoL was provided by the group of angiotensin-converting enzyme inhibitors, enalapril, significantly improving QoL.

About the authors

G. F Andreeva

National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Email: galiya-61@mail.ru
канд. мед. наук, ст. науч. сотр. лаб. применения амбулаторных диагностических методов в профилактике ХНИЗ ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3

V. M Gorbunov

National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Email: vgorbunov@gnicpm.ru
д-р мед. наук, проф., рук. лаб. применения амбулаторных диагностических методов в профилактике ХНИЗ ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3

O. V Molchanova

National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Email: ovm-337@mail.ru
канд. мед. наук, вед. науч. сотр. лаб. применения амбулаторных диагностических методов в профилактике ХНИЗ ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3

A. D Deev

National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation

Email: adeev@gnicpm.ru
канд. физ.-мат. наук, рук. лаб. биостатистики ХНИЗ ФГБУ НМИЦ ПМ 101990, Russian Federation, Moscow, Petroverigskii per., d. 10, str. 3

References

  1. Оганов Р.Г. Масленникова Г.Я. Смертность от сердечно - сосудистых и других хронических неинфекционных заболеваний среди трудоспособного населения России. Кардиоваскулярная терапия и профилактика. 2002; 3: 4-8.
  2. Collins R, Mac Mahon S. Blood pressure, antihyhertensive drug treatment and the risk of stroke and of coronary heart disease. Br Med Bull 1994; 50: 272-98.
  3. Шальнова С.А., Деев А.Д., Вихирева О.В. и др. Артериальная гипертония. Информированность, лечение, контроль. Укрепление здоровья и профилактика заболеваний. 2001; 4: 3-7.
  4. Айвазян Т.А., Зайцев В.П. Исследование качества жизни больных гипертонической болезнью. Кардиология. 1989; 9: 43-5.
  5. Crooq S.H, Levine S, Testa M.A et al. The effect of antihypertensive therapy on the quality of life. New Engl J Med 1986; 314 (26): 1657-64.
  6. Андреева Г.Ф., Горбунов В.М., Исайкина О.Ю. и др. Сравнительная оценка воздействия малых доз эналаприла и телмисартана на качество жизни и гемодинамические показатели больных со стабильной артериальной гипертензией. Рос. кардиол. журн. 2002; 4: 36-9.
  7. Beto J, Bansal V.K. Quality of life in treatment of hypertension: a metaanalysis of clinical trials. J Hypertens 1992; 5(3): 125-33.
  8. Siegrist J, Junge A. Conceftual and methodological problems in research on the quality of life in clinical medicine. Soc Sci Med 1989; 29 (3): 463-8.
  9. Zuther P, Witte K, Lemmer B. ABPM-FIT and CV-SORT: an easy - to - use software package for detailed analysis of data from ambulatory blood pressure monitoring. Blood Press Monit 1996; 1: 347-54.
  10. The World Health Organization Quality of Life (WHOQOl). BREF. WHO 2004.
  11. Андреева Г.Ф., Марцевич С.Ю., Горбунов В.М. и др. Оценка действия комбинации бетагистина дигидрохлорида с антигипертензивными препаратами на качество жизни больных со стабильной артериальной гипертензией и головокружением. Кардиоваскулярная терапия и профилактика. 2005; 3: 35-9.
  12. Pessano B, La Brocca A, Pozzallo G et al. Antihypertensive efficacy end effects on quality of life of caftopril in mild - to - moderate arterial hypertension. Minerva Med 1989; 80 (6): 595-8.
  13. Zubenko G.S, Nixon R.A. Mood elevating effect of caftopril in depression patients. Am J Psychiatry 1984; 141: 110-1.
  14. Андреева Г.Ф., Горбунов В.М., Айвазян Т.А. и др. Влияние телмисартана на психологический статус и качество жизни больных со стабильной артериальной гипертонией. Эксперим. и клин. фармакология. 2004; 67 (6): 36-40.
  15. Costall B, Kelly M.E, Naylor R.S, Tomkins D.M. ACE inhibition and cognition. The international symposium on ACE inhibition. London, 1989; p. 14-7.

Copyright (c) 2017 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies